Showing 1 - 4 results of 4 for search 'Ivo Hanke', query time: 0.02s Refine Results
  1. 1
    Encorafenib Acts as a Dual-Activity Chemosensitizer through Its Inhibitory Effect on ABCC1 Transporter In Vitro and Ex Vivo

    Encorafenib Acts as a Dual-Activity Chemosensitizer through Its Inhibitory Effect on ABCC1 Transporter In Vitro and Ex Vivo by Yu Zhang, Dimitrios Vagiannis, Youssif Budagaga, Ziba Sabet, Ivo Hanke, Tomáš Rozkoš, Jakub Hofman

    Published 2022-11-01
    Get full text
    Article
  2. 2
    Talazoparib Does Not Interact with ABCB1 Transporter or Cytochrome P450s, but Modulates Multidrug Resistance Mediated by ABCC1 and ABCG2: An in Vitro and Ex Vivo Study

    Talazoparib Does Not Interact with ABCB1 Transporter or Cytochrome P450s, but Modulates Multidrug Resistance Mediated by ABCC1 and ABCG2: An in Vitro and Ex Vivo Study by Ziba Sabet, Dimitrios Vagiannis, Youssif Budagaga, Yu Zhang, Eva Novotná, Ivo Hanke, Tomáš Rozkoš, Jakub Hofman

    Published 2022-11-01
    Get full text
    Article
  3. 3
    Surgical treatment of primary cardiac tumors: 20-year single center experience

    Surgical treatment of primary cardiac tumors: 20-year single center experience by Martin Děrgel, Ján Gofus, Petr Smolák, Václav Stejskal, Ivo Hanke, Jan Matějka, Jiří Manďák, Jan Vojáček

    Published 2022-03-01
    Get full text
    Article
  4. 4
    Tepotinib Inhibits Several Drug Efflux Transporters and Biotransformation Enzymes: The Role in Drug-Drug Interactions and Targeting Cytostatic Resistance In Vitro and Ex Vivo

    Tepotinib Inhibits Several Drug Efflux Transporters and Biotransformation Enzymes: The Role in Drug-Drug Interactions and Targeting Cytostatic Resistance In Vitro and Ex Vivo by Dimitrios Vagiannis, Youssif Budagaga, Anselm Morell, Yu Zhang, Eva Novotná, Adam Skarka, Sarah Kammerer, Jan-Heiner Küpper, Ivo Hanke, Tomáš Rozkoš, Jakub Hofman

    Published 2021-11-01
    Get full text
    Article

Search Tools: